Roivant Sciences (ROIV) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to -$0.38.
- Roivant Sciences' EPS (Weighted Average and Diluted) fell 26521.74% to -$0.38 in Q4 2025 from the same period last year, while for Dec 2025 it was -$0.65, marking a year-over-year decrease of 11058.63%. This contributed to the annual value of $0.51 for FY2025, which is 9082.96% down from last year.
- Latest data reveals that Roivant Sciences reported EPS (Weighted Average and Diluted) of -$0.38 as of Q4 2025, which was down 26521.74% from -$0.17 recorded in Q3 2025.
- In the past 5 years, Roivant Sciences' EPS (Weighted Average and Diluted) registered a high of $6.1 during Q4 2023, and its lowest value of -$0.49 during Q4 2022.
- Over the past 5 years, Roivant Sciences' median EPS (Weighted Average and Diluted) value was -$0.33 (recorded in 2025), while the average stood at $0.15.
- In the last 5 years, Roivant Sciences' EPS (Weighted Average and Diluted) soared by 134489.8% in 2023 and then plummeted by 37500.0% in 2025.
- Over the past 5 years, Roivant Sciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.41 in 2021, then fell by 19.51% to -$0.49 in 2022, then skyrocketed by 1344.9% to $6.1 in 2023, then tumbled by 96.23% to $0.23 in 2024, then tumbled by 265.22% to -$0.38 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.38 for Q4 2025, versus -$0.17 for Q3 2025 and -$0.33 for Q2 2025.